Entrada Therapeutics (TRDA) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Entrada Therapeutics (TRDA) over the last 4 years, with Q3 2025 value amounting to -$43.5 million.
- Entrada Therapeutics' Other Gross PP&E Adjustments rose 2013.39% to -$43.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.5 million, marking a year-over-year increase of 2013.39%. This contributed to the annual value of -$53.2 million for FY2024, which is 1951.58% up from last year.
- Latest data reveals that Entrada Therapeutics reported Other Gross PP&E Adjustments of -$43.5 million as of Q3 2025, which was up 2013.39% from -$44.5 million recorded in Q2 2025.
- In the past 5 years, Entrada Therapeutics' Other Gross PP&E Adjustments registered a high of -$1.0 million during Q1 2023, and its lowest value of -$72.9 million during Q2 2023.
- Over the past 4 years, Entrada Therapeutics' median Other Gross PP&E Adjustments value was -$47.4 million (recorded in 2025), while the average stood at -$42.9 million.
- In the last 5 years, Entrada Therapeutics' Other Gross PP&E Adjustments surged by 9547.89% in 2023 and then crashed by 594254.69% in 2024.
- Over the past 4 years, Entrada Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$15.5 million in 2022, then crashed by 327.26% to -$66.1 million in 2023, then grew by 19.52% to -$53.2 million in 2024, then rose by 18.13% to -$43.5 million in 2025.
- Its last three reported values are -$43.5 million in Q3 2025, -$44.5 million for Q2 2025, and -$47.4 million during Q1 2025.